Northwestern is testing experimental therapies for Crohn's disease

August 07, 2002

CHICAGO --- Researchers at the Inflammatory Bowel Disease Center at Northwestern University are conducting clinical trials of several innovative approaches to the treatment of Crohn's disease, including experimental drugs and a new swallowable video camera that produces high-quality images of the small intestine.

Research related to these Crohn's disease studies appears in the Aug. 8 issue of The New England Journal of Medine.

In addition to aiding diagnosis by affording a more complete view of the small intestine without pain or discomfort to the patient, the "camera-in-a-capsule" enables physicians to direct appropriate treatment and determine the effect of new medications for Crohn's disease.

The studies are headed by Alan Buchman, M.D., associate professor of medicine at The Feinberg School of Medicine and director of the Inflammatory Bowel Disease Center at Northwestern.

Crohn's is a serious inflammatory disease of the gastrointestinal tract that causes diarrhea, abdominal cramps, fever and rectal bleeding. The cause of Crohn's disease is unknown.

Among the experimental medications for Crohn's disease undergoing investigation at Northwestern is a synthetic, oral form of interleukin-11, a chemical produced by white blood cells in response to inflammation. This study of interleukin-11 for Crohn's disease is the first to be conducted in humans.

Research has shown that interleukin-11 is both an anti-inflammatory agent and a potent growth factor that aids in the healing process. Other drugs used to treat Crohn's disease, such as prednisone, only reduce inflammation.

In a separate study, Northwestern also is assessing the use of interleukin-11 in ulcerative colitis.

Northwestern will be studying two experimental drugs for Crohn's disease that prevent inflammation by blocking the process by which white blood cells adhere to areas of inflammation in the bowel.

Another investigational study for Crohn's disease will focus on a drug that blocks production of an inflammation-causing chemical known as tumor necrosis factor.
-end-
For information on these and other studies for the treatment of Crohn's disease and ulcerative colitis, contact the Northwestern Inflammatory Bowel Disease Center at (312) 695-4IBD (or 4423).

KEYWORDS: Crohn's disease, ulcerative colitis, inflammatory bowel disease

Northwestern News on the Web: http://www.northwestern.edu/news/

Additional Contact:
Broadcast Media: Tamara Kerrill at (847) 491-4888 or tlk@northwestern.edu

Northwestern University

Related Inflammation Articles from Brightsurf:

3D printed stents that treat inflammation
POSTECH Professor Dong-Woo Cho's research team develops bioink-loaded esophageal stents for treating radiation esophagitis.

New cause of inflammation in people with HIV identified
A new study led by researchers at Boston Medical Center examined what factors could be contributing to this inflammation, and they identified the inability to control HIV RNA production from existing HIV DNA as a potential key driver of inflammation.

Maltreatment tied to higher inflammation in girls
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse.

A protein that controls inflammation
A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Inflammation in the brain linked to several forms of dementia
Inflammation in the brain may be more widely implicated in dementias than was previously thought, suggests new research from the University of Cambridge.

Social isolation could cause physical inflammation
Social isolation could be associated with increased inflammation in the body new research from the University of Surrey and Brunel University London has found.

Hydrogels control inflammation to help healing
Researchers test a sampling of synthetic, biocompatible hydrogels to see how tuning them influences the body's inflammatory response.

Why beta-blockers cause skin inflammation
Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases.

The 'inflammation' of opioid use
New research correlates inflammation in the brain and gut to negative emotional state during opioid withdrawal.

Using a common anticonvulsant to counteract inflammation
The interaction between a chromosomal protein called HMGB1 and a cellular receptor called RAGE is known to trigger inflammation.

Read More: Inflammation News and Inflammation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.